A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)

NCT00420589 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Stopped The overall profile does not support development for obesity

Conditions

Obesity

Interventions

DRUG: taranabant
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC